Home Tags Cancer Research UK

Cancer Research UK Related Content

honeybee venom, breast cancer

Honeybee venom found to kill agressive breast cancer cells

Researchers from the University of Western Australia have found that the venom of honeybees can destroy aggressive breast cancer cells in a lab setting.
uk cancer funding, NCRI

UK cancer funding reaches £700 million for first time

The National Cancer Research Institute (NCRI) released figures today (4 February) showing that NCRI funding has reached £700 million for the first time.
stop ovarian cancer, new class of drugs

New drugs could stop ovarian cancer

Researchers at The University of Manchester have shown that a new class of drugs are able to stop ovarian cancer cells growing.

We need to think differently about cancer to save more lives

Sir Harpal Kumar, former CEO of Cancer Research UK, outlines his vision for cancer in the future and said that earlier diagnosis would enable the UK to catch up with its international counterparts in terms of survival rates and would also make the NHS more efficient
chemotherapy data

Publishing national chemotherapy data

Publishing national chemotherapy data has helped NHS hospitals make changes that should improve treatment, as Emma Saxon reveals in this article
lung cancer drug

NHS approves new ‘life extending’ lung cancer drug

After extended campaigns from charities and prominent figures, a lung cancer drug said to extend the life of sufferers has been made available on the NHS The nivolumab lung cancer drug is already available in Scotland for those with advanced lung cancer who are already undergoing chemotherapy. The immunotherapy treatment stimulates...

Pancreatic cancer: A three-pronged attack

Science Information Officer Dr Catherine Pickworth outlines the work being carried out by Cancer Research UK to fight against pancreatic cancer

New developments in breast cancer treatment found

A mechanism used by breast cancer cells to grow and spread has been discovered. This has the potential to open the way for a new generation of treatments
cancer © Panuwat Dangsungnoen

Tackling childhood cancer

Hollie Chandler, Senior Policy Advisor at Cancer Research UK highlights the work being done to improve treatment for childhood cancers In the UK around 3,800 children, teenagers and young adults are diagnosed with cancer each year, that’s 73 every week. Thanks to new treatments, survival rates are improving. More than 80% of...

China to the UK: Tackling cancer across borders

The China-United Kingdom Cancer (CUKC) Conference 2015 welcomed approximately 200 experts, including senior medics, scientists and scholars from world leading, international institutions to discuss strategies to fight cancer. The two-day event invited presentations from leading scientists and clinicians on effective cancer prevention, early diagnosis, aggressive treatment and rehabilitation recovery...

Flying the flag for cancer research

OAG highlights the efforts made by the Welsh Government to improve cancer care and research throughout the country Due to an ageing population, the demand for cancer care is ever increasing. In Wales, cancer is one of the two biggest causes of premature death, which is why tackling the disease...
Gynecologic cancer

Research at Oslo University Hospital in the field of Gynaecologic cancer

Oslo University Hospital (OUS) is a big hospital formed by the merger of 4 hospitals. The State Hospital, the Norwegian Radium Hospital, Ullevaal Hospital and Aker Hospital. It serves as a local hospital for about 600,000 inhabitants and as a referral centre for about 2.8 million people. As a...

Improved cancer care: Integrating palliative care and oncology

Norwegian cancer researchers launch a project to improve care for cancer patients with a limited life expectancy Europe has about 3.5 million new cancer cases per year, and the number is rising. Advances in treatment options have led to more patients getting cured and prolonged survival for those with incurable...
prostate cancer

The million dollar question in prostate cancer research

Owen Sharp, CEO at Prostate Cancer UK sheds light on the important work that’s being done to better diagnose and treat prostate cancer Most prostate cancers aren’t a problem. In fact, for many, the problems only come from diagnosing and treating them. These are the prostate cancers a surgeon once...

Putting skin cancer in the shade

Sarah Williams, Senior Health Information Officer at Cancer Research UK sheds light on the increased number of skin cancer diagnoses and the importance of prevention More than 100,000 cases of skin cancer are diagnosed each year in the UK. Most of those are non-melanoma skin cancer, which is much more...

Skin cancer: deadly but preventable

Jon Pleat MA DPhil FRCS(Plast), Plastic Surgeon and Scientific Advisor at SCaRF details the risks of skin cancer and how it can be prevented Skin cancer is the most common form of cancer globally. There are more than 80,000 deaths a year from its different forms. Within the UK, the incidence...
Lung cancer death rates may overtake breast cancer

Lung cancer death rates may overtake breast cancer

For the first time, the number of European women who have died as a result of lung cancer is expected to be higher than the rates for breast cancer According to the research, which appeared in the journal Annals Of Oncology, the UK and Poland have the highest lung cancer...

Some cancers are due to “bad luck”

Researchers have discovered that a number of cancers are due to "bad luck", rather than risk factors such as smoking. A new study published in the journal Science has revealed that two-thirds of cancers analysed were caused by chance mutation. The research team from the US revealed why some tissues were...
How science has contributed to cancer research

How science has contributed to cancer research

Daniel Bridge, Policy Manager at Cancer Research UK gives consideration to how science has contributed significantly to cancer research. Medical research provides the foundation of modern medicine; it is vital to tackling the health challenges of the future. We know this because of the remarkable results research has produced to...
Stem cells and personalised therapies for cancer

Stem cells and personalised therapies for cancer

Professor Alan Clarke, Director of the European Cancer Stem Cell Research Institute at Cardiff University, outlines the aim to develop more personalised therapies for patients with cancer and how targeting the cancer stem cell could be crucial in this development. Cancer remains the second largest cause of death in the western...

Follow Open Access Government